Healthcare and Life Sciences

Format: 2017-02-22
Format: 2017-02-22
May 30, 2014 | 95 Pages | SKU: IRTNTR3558

About Hypodermic Needles
A hypodermic needle is a hollow needle commonly used with a syringe to inject substances into the body or or to extract fluids from it. A hypodermic needle is used for rapid delivery of liquids or to inject substances that cannot be ingested. Hypodermic needles are broadly classified into non-safety and safety needles based on the safety feature associated with the device. Safety needles can be further segmented into active and passive devices based upon the type of user intervention required to activate the safety mechanism. Based on the mechanism of activation, active devices can be further classified as either manual and semi-automatic devices.
TechNavio's analysts forecast the Global Hypodermic Needles market will grow at a CAGR of 6.66 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Hypodermic Needles market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of non-safety and safety hypodermic needles. The revenue generated in this market can be segmented based on the following types of needle, which are classified according to the safety activation mechanism:

  • Manual
  • Semi-automatic
  • Automatic/Passive

TechNavio's report, the Global Hypodermic Needles Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions as well as individual country-wise revenue segmentation; it also covers the Global Hypodermic Needles market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA       
  • APAC

Key Vendors


May 30, 2014 | 85 Pages | SKU: IRTNTR3559

About Mechanical Ventilators
A mechanical ventilator is a life-supporting medical device used to assist or replace a patient’s breathing. A mechanical ventilation is generally the last resort for a patient who is having difficulty breathing and cannot maintain adequate oxygenation to maintain life. Patients with respiratory disorders such as COPD may require the need of mechanical ventilators. Mechanical ventilators can be positive pressure type and negative pressure type depending on the method of delivery of oxygen into the lungs by the ventilator. Positive pressure mechanical ventilators involve air (or another gas mix) being pushed into the trachea of the patient while with negative pressure mechanical ventilators the air is sucked inside. In general, mechanical ventilators are connected through an endotracheal tube that is placed in the windpipe of the patient (known as invasive ventilators). Some of the latest mechanical ventilators assist breathing through a mask or mouthpiece (non-invasive ventilators).
TechNavio's analysts forecast the Global Mechanical Ventilators market will grow at a CAGR of 6.78 percent over the period 2013-2018.

Covered in this Report
The Global Mechanical Ventilators market can be divided into three segments:

  • Critical Care Ventilators
  • Portable and Transport Ventilators
  • Neonatal Ventilators.

TechNavio's report, the Global Mechanical Ventilators Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Mechanical Ventilators market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA       
  • APAC

Key Vendors


May 30, 2014 | 90 Pages | SKU: IRTNTR3616

About Pain Management Devices
Pain management devices are used for reducing pain and improving quality of life. Pain can be caused due to chronic diseases such as cancer, arthritis and diabetes or due to trauma, injury or surgery. Sometimes pain persists for weeks, months or even years. This is called chronic pain.  Pain disorder is common among the aged population. Minimally invasive devices have been developed for treatment of pain that reoccurs after few years of surgery
TechNavio's analysts forecast the Global Pain Management Devices market will grow at a CAGR of 9.51 percent over the period 2013-2018.

Covered in this Report
The Global Pain Management Devices market can be segmented into three divisions: Neurostimulation Devices (SCS, DBS and SNS devices), Electrical Stimulation Devices (TENS devices), and Analgesic Infusion Pumps (PCA and Intrathecal pumps).
TechNavio's report, the Global Pain Management Devices Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pain Management Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA       
  • APAC

Key Vendors

  • Boston Scientific Corp.
  • DJO Global, Inc.
  • Kimberly-Clark Corp.
  • Medtronic, Inc.
  • St. Jude Medical, Inc.

Other Prominent Vendors

  • Baxter Healthcare Corp.
  • B. Braun Melsungen AG
  • BioMedical Life Systems, Inc.
  • Bio-Medical Research (BMR) Ltd
  • CME Medical
  • Codman And Shurtleff, Inc.
  • GF Health Products, Inc.
  • Flowonix Medical, Inc.
  • International

May 30, 2014 | 84 Pages | SKU: IRTNTR3618

About Uveitis
Uveitis is defined as the inflammation of the middle layer of the eye i.e. the uvea, also known as the uceal tract. The uvea consists of the iris, choroid and ciliary body. Infections, injury and autoimmune disorders may be related with the development of uveitis; however, the exact cause is often unknown. Various types of uveitis are: anterior uveitis, intermediate uveitis, posterior uveitis, and pan uveitis. The most common type of uveitis is an inflammation of the iris called iritis (anterior uveitis). Uveitis can be serious, leading to permanent vision loss.
TechNavio's analysts forecast the Global Uveitis market will grow at a CAGR of 26.46 percent over the period 2013-2018.

Covered in this Report
The Global Uveitis market can be segmented into three divisions: the Americas, and the EMEA and APAC regions.  To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of uveitis.
TechNavio's report, the Global Uveitis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Uveitis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA       
  • APAC

Key Vendors

  • Abbvie Inc.
  • Alcon Laboratories Inc.
  • Allergan Inc.
  • Bausch & Lomb Inc.

Other Prominent Vendors

  • Artielle ImmunoTherapeutics Inc.
  • Enzo Biochem Inc.
  • Hanall Pharmaceutical Co. Ltd.
  • Lux Biosciences Inc.
  • OphthaliX Inc.
  • Regeneron Pharmaceuticals Inc.
  • TopiVert Ltd.
  • pSivida Corp.
  • XOMA

May 23, 2014 | 119 Pages | SKU: IRTNTR3605

About Non-melanoma Skin Cancer
Non-melanoma skin cancer is one of the most common types of cancer in the world. It develops in the upper layers of the skin, but not in melanocytes. There are two types of non-melanoma skin cancer: BCC, which starts in the basal cells, and SCC, which starts in the squamous cells. BCC usually develops in the areas such as the head and neck, whereas SCC starts in the face, ears, neck, lips, and backs of the hands. These can also grow in wounds or chronic skin sores. Non-melanoma skin cancer is caused by unprotected and excessive exposure to UV radiation. It affects men more than women. It can be cured effectively if it is detected early. Treatment for non-melanoma skin cancer includes surgery, laser therapy, cryotherapy, creams, radiotherapy, chemotherapy, and PDT.
TechNavio's analysts forecast the Global Non-melanoma Skin Cancer market to grow at a CAGR of 27.93 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Non-melanoma Skin Cancer market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the following segments:

  • Chemotherapy, which includes drugs used in the treatment of SCC, BCC, and actinic keratosis
  • Non-invasive Treatments, which include PDT, radiotherapy, cryotherapy, and laser therapy

TechNavio's report, the Global Non-melanoma Skin Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and, the EMEA and the APAC region; and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors

  • Elekta AB
  • F. Hoffmann-la Roche Ltd.
  • iCAD Inc.
  • Meda AB
  • Valeant

May 09, 2014 | 55 Pages | SKU: IRTNTR3501

About Diabetic Neuropathy
Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission.  About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.
TechNavio's analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the


Pages